Why AMC Entertainment Is Trading Lower By 33%; Here Are 31 Stocks Moving Premarket

Gainers

• Kiromic BioPharma, Inc. (NASDAQ:KRBP) shares rose 48.5% to $0.56 in pre-market trading. Kiromic Biopharma said the company has determined not to pursue, at this time, the contemplated public offering to which the registration statement relates.
• MSP Recovery, Inc. (NASDAQ:MSPR) shares rose 37.2% to $2.95 in pre-market trading after the company issued a business update. MSP Recovery recently posted Q2 loss of $0.09 per share.
• Signify Health, Inc. (NYSE:SGFY) rose 36.8% to $29.00 in pre-market trading after the Wall Street Journal reported that Amazon is among the potential bidders for the healthcare company, along with the previously reported CVS.
• Wag! Group Co. (NASDAQ:PET) rose 34.8% to $7.00 in pre-market trading after jumping around 9% on Friday. DA Davidson maintained buy on Wag Group and lowered price target to $11 .
• AnPac Bio-Medical Science Co., Ltd. (NASDAQ:ANPC) rose 28% to $0.2745 in pre-market trading after declining 8% on Friday. Anpac Bio-Medical Science recently named Yuyang Cui as Co-Chairman and co-CEO.
• Reborn Coffee, Inc. (NASDAQ:REBN) rose 21.9% to $4.45 in pre-market trading after declining 8% on Friday. Reborn Coffee recently announced closing of upsized $7.2 million initial public offering.
• Graphex Group Limited (NASDAQ:GRFX) shares rose 20.4% to $3.01 in pre-market trading after gaining 21% on Friday. Graphex Group reported closing of upsized $11.7 million public offering and NYSE American listing.
• Greenbrook TMS Inc. (NASDAQ:GBNH) rose 17.5% to $3.61 in pre-market trading after jumping around 30% on Friday.
• 180 Life Sciences Corp. (NASDAQ:ATNF) rose 14% to $1.08 in pre-market trading. 180 Life Sciences, last month, announced a $6.5 million registered direct offering.
• Better Therapeutics, Inc. (NASDAQ:BTTX) shares rose 13.1% to $1.81 in pre-market trading. Better Therapeutics recently reported Q2 R&D expenses of $4.2 million.
• GigaCloud Technology Inc. (NASDAQ:GCT) rose 11% to $53.29 in pre-market trading after jumping 206% on Friday.
• Apexigen, Inc. (NASDAQ:APGN) rose 10.8% to $6.17 in pre-market trading after declining around 5% on Friday.
• Austin Gold Corp.(NYSE:AUST) rose 10.7% to $1.86 in pre-market trading.
• Kala Pharmaceuticals, Inc. (NASDAQ:KALA) rose 9.4% to $0.3391 in pre-market trading. Kala Pharmaceuticals reported inducement grant under NASDAQ listing rule 5635(c)(4).
• Adagio Therapeutics, Inc (NASDAQ:ADGI) rose 9.1% to $4.58 in pre-market trading after declining around 7% on Friday. Adagio Therapeutics recently posted a Q2 loss of $0.47 per share.
• Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) rose 7.3% to $0.9090 in pre-market trading after dropping 17% on Friday.
• Veru Inc. (NASDAQ:VERU) rose 7% to $18.70 in pre-market trading. Veru named Jason Davies as Executive Vice President – General Manager of Europe, the Middle East and Africa (EMEA), Latin America (LATAM), and Asia Pacific (APAC)

for Veru’s Infectious Disease Franchise for Veru International.

Don’t forget to check out our premarket coverage here .

Losers

• AMC Entertainment Holdings, Inc. (NYSE:AMC) shares fell 33% to $12.08 in pre-market trading after Cineworld confirmed possible bankruptcy filing.
• Assure Holdings Corp. (NASDAQ:IONM) fell 30% to $0.98 in pre-market trading after the company reported a proposed underwritten public offering of common stock.
• Advanced Emissions Solutions, Inc. (NASDAQ:ADES) shares fell 20.4% to $5.10 in pre-market trading after the company reported a merger with Arq Limited.
• Golden Sun Education Group Limited (NASDAQ:GSUN) fell 16.5% to $42.30 in pre-market trading after dropping 23% on Friday.
• Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE) fell 13.4% to $0.7879 in pre-market trading. Aeglea BioTherapeutics shares jumped 80% on Friday after the company announced a marketing authorization application for pegzilarginase for the treatment of Arginase 1 deficiency has been submitted to and successfully validated by the European Medicines Agency.
• Heart Test Laboratories, Inc. (NASDAQ:HSCS) fell 12% to $1.76 in pre-market trading after dropping over 10% on Friday. Heart Test Laboratories was recently granted European Patent titled 'Electrode And Cable Connections In Electrocardiography Systems.'
• OncoCyte Corporation (NASDAQ:OCX) fell 11.5% to $0.80 in pre-market trading. OncoCyte recently posted a Q2 loss of $0.07 per share.
• Hydrofarm Holdings Group, Inc. (NASDAQ:HYFM) fell 11.3% to $3.77 in pre-market trading. The company's co-CEO, last week, disclosed a purchase of 25,000 shares at an average price of $3.73 per share.
• Nova LifeStyle, Inc. (NASDAQ:NVFY) fell 10.6% to $0.80 in pre-market trading. Nova Lifestyle recently posted Q2 sales of $3.80 million.
• Marker Therapeutics, Inc. (NASDAQ:MRKR) fell 10.2% to $0.3104 in pre-market trading. Marker Therapeutics recently posted a Q2 loss of $0.11 per share.
• Otonomy, Inc. (NASDAQ:OTIC) shares fell 9.5% to $0.3801 in pre-market trading on volatility.
• Plains GP Holdings, L.P. (NASDAQ:PAGP) fell 8.3% to $10.95 in pre-market trading. The company recently released Q2 results.
• StoneCo Ltd. (NASDAQ:STNE) fell 6.4% to $8.49 in pre-market trading. StoneCo shares dropped 22% on Friday after the company reported Q2 earnings results.
• GameStop Corp. (NYSE:GME) fell 5.6% to $34.45 in pre-market trading after dropping around 4% on Friday.